All posts in “telemedicine”

Keeps parent company Thirty Madison raises $15 million to fight male pattern baldness

Thirty Madison, the healthcare startup behind the hair loss brand Keeps, has brought in a $15.25 million Series A co-led by Maveron and Northzone.

The company provides a subscription-based online marketplace for men’s hair loss prevention medications Finasteride and Minoxidil. Keeps sells these drugs direct-to-consumer, working with manufacturers to keep the costs low.

On Keeps, a subscription of Minoxidil, an over-the-counter topical treatment often referred to as Rogaine, is $10 monthly. A subscription to Finasteride, a prescription drug taken daily, is $25 per month.

It’s an end-to-end platform that is the single best place for guys who are looking to keep their hair,” Thirty Madison co-founder Steven Gutentag told TechCrunch.

Keeps is tapping into a big market. According to the American Hair Loss Association, two-thirds of American men experience some hair loss by the age of 35.

You may have heard of Hims, a venture-backed men’s healthcare company that similarly sells subscriptions to hair loss treatments, as well as oral care, skin care and treatments for erectile dysfunction. Keeps is its smaller competitor. For now, the company is focused solely on haircare, though with the new funds, Thirty Madison plans to launch Cove, a sister brand to Keeps that will provide treatments to migraine sufferers.

The company was founded last year by Gutentag and Demetri Karagas with a plan to develop several digital healthcare brands under the Thirty Madison umbrella.

“Going through this process myself of starting to experience hair loss, I was not sure where to turn,” Gutentag said. “I went online and looked up ‘why am I losing my hair,’ and if you search on Google, really for any medical condition, you usually walk away thinking you’re going to die … I was so fortunate that I got access to this high-quality specialist who could help me with my problem and I was in the position to afford those treatments but most people don’t get that access.”

Keeps also provide digital access to a network of doctors at a cost of roughly $30 per visit.

TechCrunch’s Connie Loizos wrote last year that “it’s never been a better time to be a man who privately suffers from erectile dysfunction, premature ejaculation or hair loss” because of advances and investments in telemedicine. Since then, even more money has been funneled into the space.

Hims has raised nearly $100 million to date and is rumored to be working on a line of women’s products. Roman, a cloud pharmacy for erectile dysfunction, raised an $88 million Series A last month and is launching a “quit smoking kit.” And Lemonaid Health, which also provides prescriptions to erectile dysfunction medications and more, secured $11 million last year.

Greycroft, Steadfast Venture Capital, First Round, Entrepreneurs Roundtable, HillCour and Two River also participated in Thirty Madison’s fundraise, which brings its total raised to date to $22.75 million.

Sequoia backs Maven, a virtual health clinic for women

Despite the increase in women in the U.S. workforce and public pledges from several high-profile CEOs to close the gender pay gap, women, especially working mothers, often find themselves without the resources necessary to succeed at work.

Maven, a digital health startup and benefits platform focused on improving access to healthcare for women, has emerged specifically to help businesses help their female employees.

Maven has garnered the support of Sequoia Capital, a household name in Silicon Valley and a venture capital firm that has seldom backed female-focused businesses. Today, the company is announcing a $27 million Series B co-led by Sequoia and Oak HC/FT. Existing investors Spring Mountain Group, 14W and Female Founders Fund have also participated in the round.

As part of the deal, Sequoia’s Jess Lee and Oak’s Nancy Brown will join Maven’s all-female board of directors.

The company was founded by Kate Ryder, a journalist-turned-venture capitalist-turned-founder. Before joining Index Ventures as an early-stage investor in 2012, Ryder was a reporter at The New Yorker and The Economist.

During her time as a VC, digital health and telemedicine were the nascent sectors to watch. Professionally, Ryder realized the huge market opportunity, meanwhile, personally, she was reminded of the major lack of resources for women at work.

“A lot of my friends started having kids while I was working in venture capital, so I started hearing about the difficulties of having kids or postpartum depression,” Ryder told TechCrunch. “It’s not like you as a woman get educated on what all this is while you’re in school.”

In 2014, Ryder left her VC job to create Maven . Her goal: become a one-stop shop for working women starting families. Since launching the company, Ryder herself has become a mother of two.

“You go through this enormous life experience; it’s hugely transformative to have a child,” she said. “You do it when your careers is moving up — they call it the rush hour of life — and with no one supporting you on the other end, it’s easy to say ‘screw it, I’m going home to my family’ … If someone leaves the workforce, that’s fine, it’s their choice but they shouldn’t feel forced to because they don’t have support.”

Maven partners with companies, including Snap and Bumble, to provide employees access to its women’s and family health provider network. The platform connects users to OB-GYNs, pediatricians, therapists, career coaches and other services including resources for families interested in adoption, IVF or maternity care.

Users can also video chat or direct message healthcare practitioners using the Maven app.

Along with the Series B financing, Maven is announcing the launch of a breastmilk service, Maven Milk, which it says is its next step toward closing the resource and care gap for working mothers.

Erectile pharmacy app Roman raises $88M to launch ‘quit smoking’ kit

Roman is a rocket ship, and I’m not talking about how it sells Viagra and Cialis. Less than a year after launching its cloud pharmacy for erectile dysfunction with $3 million in funding and a five-person team, Roman has grown to seventy team members and a revenue run-rate in the 10s of millions — up 720 percent since January. It’s sparked over a million patient-physician visits, phone calls, and text conversations through its telemedicine portal for getting diagnoses and prescriptions.

And now Roman is ready to expand beyond men, so it’s dropping the ‘Man.

Today, the newly renamed ‘Ro’ unveiled its next product, Zero, a $129 ‘quit smoking’ kit. It contains a month’s worth of prescription cessation medication bupropion and nicotine gum, plus an app for tracking progress and learning how to stay motivated through hunger, nausea, and cravings. Pre-orders open today.

“Erectile dysfunction medication is a knee brace. It helps you to walk again but the goal would be to not need a knee brace” says Ro co-founder Zachariah Reitano, who started the company because he lives with ED himself due to a heart medication side effect. “Some people will need ED medication but we’re hoping that a lot of people, through lifestyle changes or quitting smoking, won’t need us any more.”

To get the word out about Zero to women and men alike, as well as build a physician’s electronic medical record system, Ro has also raised a jaw dropping $88 million Series A round. It was led by FirstMark Capital and joined by SignalFire, Initialized Capital, General Catalyst, Slow Ventures, Sinai Ventures, Torch Capital, BoxGroup, and Tusk Ventures. Initialized and Reddit co-founder Alexis Ohanian and FirstMark managing director Rick Heitzmann will both join Ro’s board to steward this massive infusion of capital.

Roman board member Alexia Ohanian sporting a Roman Zero hat while cheering on his wife, tennis star Serena Williams

“The plan for the money is to continue to build out our own pharmacy” as well as “a lot of the backend infrastructure that we call ‘Ro’ that will allow us to launch these other products and verticals over the next two to three years, including women’s health products, Reitano tells me. Ohanian writes that “The only thing that exceeds Ro’s execution to date is their vision for the future of healthcare. Unlike other companies in the space, Ro is full-stack and is actually rebuilding the health care experience from the ground up, which means they are able to deliver unrivaled care for patients across the country.”

Ro’s Zero kit

Until recently, 80 percent of Viagra sold online was counterfeit. That not only made it awkward to buy medication for erectile dysfunction, but also dangerous. Yet that number is starting to drop thanks to the explosion in popularity of Roman, as well as fellow direct-to-consumer men’s health startup Hims. “Roman doesn’t lend itself to the typical Instagram unboxing experience, but we get a lot of one-to-one word of mouth” Reitano says with a chuckle. SEO has also been key to revenue growth, as its the first organic search result for ‘buy Viagra’.

One of the thing that’s helped has been me sharing my story [he’s dealt with ED since he was 17], and this ‘check engine light’ concept” that views erections as indicators that a man’s body is in working order. Roman even built a somewhat-silly app called Morning Glory to help men track morning erections. Roman’s whole experience is designed to make patients comfortable with a fundamentally uncomfortable topic. “The fact that this stigma exists is why people don’t talk to their doctor or their partner” Reitano says.

Roman co-founder Zachariah Reitano

Now Ro wants to take the same clear-eyed approach to helping people quit smoking, starting by getting you to chat with its “telehealth assistant” to get paperwork sorted before you speak with a Ro doctor. The startup says that of the 37.5 million people in the US who smoke, 70 percent want to quit and 50 percent try to quit each year, but only 3 to 5 percent are smoke-free after six months. But with medication, nicotine replacement therapy like gum, tapering down smoking before stopping, and counseling, the quit rate drastically improves to 33 percent after six months.

You get all that from Zero’s kit for $129 per month, compared to $120 on Amazon for just the nicotine gum. Reitano admits that “the margin actually is not fantastic to start. Let’s say it’s slightly below what a typical commerce purchase would be.” But the idea is that if Ro and Zero can help someone quit smoking, patients will turn to it for more of their online pharmacy needs.

One barrier for Ro is that it currently doesn’t accept insurance for its $15 telemedicine appointments, Roman pills, or the Zero kit. Eventually it wants to accept FSA cards for tax-favored spending in hopes of reducing the cost for some patients, but otherwise Ro will require people to pay out-of-pocket, restricting it to wealthier segment of the population. Reitano admits that “In any space that’s incredibly competitive and highly regulated, there are things out of your control. In our control, there’s an incredible opportunity to make sure we take advantage of the infrastructure we have.”

Reitano concludes, “Honestly, I hope we can live up to what we want to build.”

Nurx raises $36 million and adds Chelsea Clinton to its board of directors

Telemedicine startup Nurx recently closed a $36 million funding round led by Kleiner Perkins. As part of the investment, Kleiner Perkins General Partner Noah Knauf is joining the startup’s board of directors, along with and Chelsea Clinton .

With this new funding, CEO and co-founder Hans Gangeskar told TechCrunch that the startup plans to scale its clinical teams, pharmacies and geographic reach in the coming year.

“We have a new site in Miami where we have a team of nurses being on-boarded, [we’re] building out our engineering and design teams and really just [working to] increase the pace of everything that we’re doing” Gangeskar said.

The startup launched in 2014 with the goal to make reliable access to contraceptives as easy as opening your web browser. After plugging your information into its online app, users are connected with physicians, given a prescription and Nurx prepares their product for delivery.

Since its launch, this California-based startup now operates in 17 states, and has expanded its products to include not only contraceptives (such as pills, patches, injectables and products like Nuva Ring) but the anti-HIV medication PrEP as well. Gangesker says the company is also preparing to launch an at-home lab kit soon for HIV testing.

For Gangeskar, creating affordable access to contraceptives is a first step to changing how patients interact and receive medication from their physicians.

“Birth control is one of the fundamental functions of any health care system [so] for us its a natural place to start,” said Gangeskar.

To help advance its plans to redefine this space, Gangeskar says Nurx is excited to welcome public health veteran Chelsea Clinton to its board.

“Her experience in public health and global health from the Clinton Global Initiative has been really valuable, [particularly learning about] rolling out preventative services in large scales, because really that’s the potential of our platform — [to reach] populations that can’t be reached by the conventional medical system.”

While Washington looks to make cuts to American’s health care access, startups like Nurx offer a fresh perspective on this critical space.

Kangpe is a mobile service connecting Africa to healthcare


Healthcare in Africa might conjure up an image of some physician working in a remote village via Doctors without Borders but mobile technology is rapidly changing the entire continent and Y Combinator startup Kangpe Health aims to cash in by providing Africans with a platform to contact doctors remotely through their mobile devices.

People access Kangpe’s platform by firing up the mobile app on either a simple or smartphone and typing in medical questions. Medical staff will then answer those questions for a small fee in what should be 10 minutes or less or refer the customer to a doctor who can help them further.

Friends Femi Kuti, Ope Olumeken and Matthew Mayaki launched Kangpe in Nigeria last year but Kuti came up with the idea originally while working as a doctor in the country. As he tells it, friends and patients would constantly hit him up over text about their symptoms and he thought it would be a good idea to turn the advice he was giving out for free into a startup.

Kangpe now operates in Ghana and Kenya as well, potentially serving a combined population of roughly 245 million people at the moment. According to Kuti, the startup has so far on-boarded 60,000 users.

Of course, it’s not the first to come up with the idea. Those in the U.S. can access similar remote physician platforms like Doctor on Demand or the text-based First Opinion for a medical question. There’s also MedAfrica in Kenya, Matibabu in Uganda and Hello Doctor, which currently operates in about 10 African countries.

However, with the fast-paced adoption of new technology and growth trajectory of several African nations, the field is still pretty wide for pulling in potential customers.

Kuti also points out the platforms working in the U.S. don’t exactly translate to care in Africa. “Google doesn’t know about African disease,” he says.

Kangpe has already sparked some social interest and has forged a partnership with Facebook as the top service on Facebook’s Free Basics program for Nigeria. You can see the promotional video Facebook put together to help promote Kangpe on Free Basics below.

But in the future, the founder says he’d really like Kangpe to become the “Oscar Health to Africa” by connecting people to initial consultations, health insurance or further medical care through the platform.

“We’re really trying to give African people access to healthcare at a price point that makes sense to them,” Kuti said.

[embedded content]